BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9613785)

  • 1. Analysis of the value of empiric vancomycin administration in febrile neutropenia occurring after autologous peripheral blood stem cell transplants.
    Koya R; Andersen J; Fernandez H; Goodman M; Spector N; Smith R; Hanlon J; Cassileth PA
    Bone Marrow Transplant; 1998 May; 21(9):923-6. PubMed ID: 9613785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Febrile neutropenia in paediatric peripheral blood stem cell transplantation, in -vitro sensitivity data and clinical response to empirical antibiotic therapy.
    Ansari SH; Nasim S; Ahmed A; Irfan M; Ishaque A; Farzana T; Panjwani VK; Taj M; Shamsi TS
    J Coll Physicians Surg Pak; 2006 Nov; 16(11):704-8. PubMed ID: 17052420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infectious complications after autologous peripheral blood progenitor cell transplantation followed by G-CSF.
    Offidani M; Corvatta L; Olivieri A; Rupoli S; Frayfer J; Mele A; Manso E; Montanari M; Centurioni R; Leoni P
    Bone Marrow Transplant; 1999 Nov; 24(10):1079-87. PubMed ID: 10578158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Febrile neutropenia in allogeneic and autologous peripheral blood stem cell transplantation and conventional chemotherapy for malignancies.
    Celebi H; Akan H; Akçağlayan E; Ustün C; Arat M
    Bone Marrow Transplant; 2000 Jul; 26(2):211-4. PubMed ID: 10918433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical impact of antibacterial prophylaxis and cycling antibiotics for febrile neutropenia in a hematological malignancy and transplantation unit.
    Craig M; Cumpston AD; Hobbs GR; Devetten MP; Sarwari AR; Ericson SG
    Bone Marrow Transplant; 2007 Apr; 39(8):477-82. PubMed ID: 17322937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Imipenem combined with teicoplanin or vancomycin in the initial empirical treatment of febrile neutropenia. Analysis of the primary response and of a global sequential strategy in 126 episodes].
    Figuera A; Tomás JF; Hernández L; Jiménez ML; Peñarrubia MJ; del Rey MC; Arranz R; Cámara R; López-Lorenzo JL; Fernández-Rañada JM
    Rev Clin Esp; 1996 Aug; 196(8):515-22. PubMed ID: 8984537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Value of mono-antibiotic therapy using piperacillin associated with sulbactam and possibly followed by vancomycin in febrile neutropenia in solid tumors].
    Abs L; Kattan J; Culine S; Bekradda M; Farhat F; Droz JP
    Bull Cancer; 1994 Oct; 81(10):871-6. PubMed ID: 7734770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized prospective study comparing cost-effectiveness of teicoplanin and vancomycin as second-line empiric therapy for infection in neutropenic patients.
    Vázquez L; Encinas MP; Morín LS; Vilches P; Gutiérrez N; García-Sanz R; Caballero D; Hurlé AD
    Haematologica; 1999 Mar; 84(3):231-6. PubMed ID: 10189388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of febrile neutropenic patients with cancer who require hospitalization: a prospective randomized study comparing imipenem and cefepime.
    Raad II; Escalante C; Hachem RY; Hanna HA; Husni R; Afif C; Boktour MR; Whimbey EE; Kontoyiannis D; Jacobson K; Kantarjian H; Levett LM; Rolston KV
    Cancer; 2003 Sep; 98(5):1039-47. PubMed ID: 12942573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cefepime versus ticarcillin and clavulanate potassium and aztreonam for febrile neutropenia therapy in high-dose chemotherapy patients.
    Fleming DR; Ziegler C; Baize T; Mudd L; Goldsmith GH; Herzig RH
    Am J Clin Oncol; 2003 Jun; 26(3):285-8. PubMed ID: 12796602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and outcome of vancomycin-resistant enterococcal bacteremia following autologous peripheral blood stem cell transplantation.
    Kapur D; Dorsky D; Feingold JM; Bona RD; Edwards RL; Aslanzadeh J; Tutschka PJ; Bilgrami S
    Bone Marrow Transplant; 2000 Jan; 25(2):147-52. PubMed ID: 10673672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Piperacillin/tazobactam vs ceftazidime in the treatment of neutropenic fever in patients with acute leukemia or following autologous peripheral blood stem cell transplantation: a prospective randomized trial.
    Harter C; Schulze B; Goldschmidt H; Benner A; Geiss HK; Hoppe-Tichy T; Ho AD; Egerer G
    Bone Marrow Transplant; 2006 Feb; 37(4):373-9. PubMed ID: 16400334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vancomycin does not benefit persistently febrile neutropenic people with cancer.
    Wade JC; Glasmacher A
    Cancer Treat Rev; 2004 Feb; 30(1):119-26. PubMed ID: 14766129
    [No Abstract]   [Full Text] [Related]  

  • 14. Prophylactic antibiotics for the prevention of neutropenic fever in patients undergoing autologous stem-cell transplantation: results of a single institution, randomized phase 2 trial.
    Eleutherakis-Papaiakovou E; Kostis E; Migkou M; Christoulas D; Terpos E; Gavriatopoulou M; Roussou M; Bournakis E; Kastritis E; Efstathiou E; Dimopoulos MA; Papadimitriou CA
    Am J Hematol; 2010 Nov; 85(11):863-7. PubMed ID: 20882526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of obtaining blood cultures in febrile neutropenic patients undergoing bone marrow transplantation.
    Serody JS; Berrey MM; Albritton K; O'Brien SM; Capel EP; Bigelow SH; Weber DJ; Gabriel ; Wiley JM; Schell MJ; Gilligan PH; Shea TC
    Bone Marrow Transplant; 2000 Sep; 26(5):533-8. PubMed ID: 11019843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized comparison of empiric or pre-emptive antibiotic therapy after hematopoietic stem cell transplantation.
    Slavin MA; Grigg AP; Schwarer AP; Szer J; Spencer A; Sainani A; Thursky KA; Roberts AW
    Bone Marrow Transplant; 2007 Jul; 40(2):157-63. PubMed ID: 17468774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Febrile neutropenia. Etiology of infection, empirical treatment and prophylaxis.
    Eltahawy AT
    Saudi Med J; 2003 Apr; 24(4):331-6. PubMed ID: 12754528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of early neutropenic fever, with or without bacterial infection, is still a significant complication after reduced-intensity stem cell transplantation.
    Hori A; Kami M; Kim SW; Chizuka A; Kojima R; Imataki O; Sakiyama M; Hamaki T; Onishi Y; Usubuchi N; Kishi Y; Murashige N; Tajima K; Miyakoshi S; Heike Y; Masuo S; Taniguchi S; Takaue Y
    Biol Blood Marrow Transplant; 2004 Jan; 10(1):65-72. PubMed ID: 14752781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aerobic bacterial and fungal infections in peripheral blood stem cell transplants.
    Aksu G; Ruhi MZ; Akan H; Bengisun S; Ustün C; Arslan O; Ozenci H
    Bone Marrow Transplant; 2001 Jan; 27(2):201-5. PubMed ID: 11281391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infectious complications after autologous hematopoietic stem cell transplantation: comparison of patients with acute myeloid leukemia, malignant lymphoma, and multiple myeloma.
    Auner HW; Sill H; Mulabecirovic A; Linkesch W; Krause R
    Ann Hematol; 2002 Jul; 81(7):374-7. PubMed ID: 12185506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.